Found 10 matching trials
A Clinical Study to Test the Efficacy and Safety of CSL312 on Catheter-associated Blood Clot Formation in Subjects With Cancer Who Receive Chemotherapy Through a PICC Line PHASE1 Peripherally Inserted Central Catheters (PICCs) are commonly used in patien...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study in Subjects â„ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab PHASE4 This study is designed to evaluate the safety after switching to garadacima...
Show More Location
Research Solutions of Arizona
Learn More & Join Trial
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks PHASE3 This phase 3b study will evaluate long-term safety and efficacy of CSL312 (...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks PHASE3 This is a multicenter, double-blind, randomized, placebo-controlled, parall...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE) N/A This is a multinational, multicenter, prospective, observational cohort stu...
Show More Location
Medical Research of Arizona
Learn More & Join Trial
A Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian Adults PHASE1 This will be a 2- part, phase 1, open-label, single center, single ascendin...
Show More Location
Anaheim Clinical Trials, LLC
Learn More & Join Trial
Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study N/A This protocol for post study access allows pediatric participants (2-11 yea...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) PHASE2 This is a prospective, phase 2, multicenter, randomized, double blind, plac...
Show More Location
Nova Clinical Research, LLC
Learn More & Join Trial
Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis PHASE2 This is a prospective, phase 2a, multicenter, randomized, double-blind, pla...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema PHASE3 The purpose of this study is to investigate the safety, PK / PD, and effica...
Show More Location
Research Solutions of Arizona
Learn More & Join Trial